Krish Patel is a clinical investigator and Director of the Lymphoma Program at the Swedish Cancer Institute (SCI) in Seattle, Washington. Dr. Patel completed his medical school, residency, and fellowship training at Duke University School of Medicine where he served as a Chief Resident in Internal Medicine. In 2016, he joined the Swedish Cancer Institute Center for Blood Disorders and Stem Cell Transplantation as a clinical investigator. Clinically, he is focused on all aspects of lymphoma and CLL related care. He has a particular research interest in the development of novel targeted agents, immunotherapies, and cellular therapies to advance care for patients with lymphoid malignancies. He is currently a principal investigator for numerous phase I-III therapeutic lymphoma and CLL clinical trials at SCI.